gosogliptin   Click here for help

GtoPdb Ligand ID: 7413

Synonyms: PF-00734200
PDB Ligand
Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 64.6
Molecular weight 366.2
XLogP 0.67
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(N1CCC(C1)(F)F)C1NCC(C1)N1CCN(CC1)c1ncccn1
Isomeric SMILES O=C(N1CCC(C1)(F)F)[C@H]1NC[C@H](C1)N1CCN(CC1)c1ncccn1
InChI InChI=1S/C17H24F2N6O/c18-17(19)2-5-25(12-17)15(26)14-10-13(11-22-14)23-6-8-24(9-7-23)16-20-3-1-4-21-16/h1,3-4,13-14,22H,2,5-12H2/t13-,14-/m0/s1
InChI Key QWEWGXUTRTXFRF-KBPBESRZSA-N
No information available.
Summary of Clinical Use Click here for help
Gosogliptin is an experimental dipeptidyl peptidase 4 (DPP4) inhibitor. DPP4 inhibitors are used to treat type 2 diabetes.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Gosogliptin is a selective oral dipeptidyl peptidase-4 (DPP4) inhibitor. Inhibition of this enzyme increases levels of glucagon-like peptide 1 (GLP-1). This in turn, inhibits glucagon production from pancreatic α-cells and increases production of insulin from pancreatic β-cells.